Almenoff June Sherie
Insider CIK 1492647 · BCLI Director · OHRP Director · ATNM Director · FURX President, Director · AVTX Director · INNT COO and Chief Medical Officer · TENX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2026-09-02 | 2026-09-04 | 27,000 | — | $0 | 27,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award | 2026-09-02 | 2026-09-04 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2026-09-02 | 2026-09-04 | 27,000 | — | $0 | 27,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award | 2026-09-02 | 2026-09-04 | 18,000 | — | $0 | 18,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2026-01-09 | 2026-01-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2025-11-18 | 2025-11-19 | 1,900 | $7.52 | $14.3K | 1,993 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2025-11-18 | 2025-11-20 | 1,900 | $7.52 | $14.3K | 1,993 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2025-11-17 | 2025-11-19 | 93 | $7.15 | $665 | 93 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2025-11-17 | 2025-11-20 | 93 | $7.15 | $665 | 93 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2025-07-01 | 2025-07-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 20,100 | — | $0 | 20,100 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 50,000 | — | $0 | 0 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 6,333 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 3,167 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2024-12-10 | 2024-12-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2024-11-13 | 2024-11-14 | 500 | $13.00 | $6.5K | 1,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2024-11-12 | 2024-11-14 | 500 | $12.50 | $6.3K | 500 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2024-11-01 | 2024-11-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2024-08-13 | 2024-08-14 | 9,500 | — | $0 | 9,500 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2024-08-13 | 2024-08-14 | 24,600 | — | $0 | 24,600 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2023-12-20 | 2023-12-21 | 3,334 | — | $0 | 3,334 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2023-06-30 | 2023-07-05 | 4,575 | — | $0 | 4,575 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2023-03-31 | 2023-04-04 | 1,167 | — | $0 | 1,167 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2022-12-30 | 2023-01-03 | 410 | — | $0 | 410 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2022-09-30 | 2022-10-03 | 605 | — | $0 | 605 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2022-06-30 | 2022-07-01 | 4,338 | — | $0 | 4,338 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2022-06-14 | 2022-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2022-06-09 | 2022-06-10 | 5,000 | — | $0 | 5,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2022-03-31 | 2022-04-04 | 2,985 | — | $0 | 2,985 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2021-12-31 | 2022-01-04 | 737 | — | $0 | 737 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | A Award | 2021-12-15 | 2021-12-17 | 2,000 | — | $0 | 6,000 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | A Award | 2021-12-10 | 2021-12-10 | 2,000 | — | $0 | 4,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2021-11-10 | 2021-11-12 | 80,000 | — | $0 | 80,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2021-06-10 | 2021-06-15 | 6,250 | — | $0 | 6,250 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | A Award | 2019-12-12 | 2020-02-14 | 2,000 | — | $0 | 2,000 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | P Buy | 2019-01-04 | 2019-01-08 | 1,475 | $3.39 | $5.0K | 7,175 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-08-27 | 2018-08-28 | 100 | $4.94 | $494 | 900 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-08-27 | 2018-08-28 | 253 | $4.96 | $1.3K | 800 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-08-27 | 2018-08-28 | 47 | $4.90 | $230 | 547 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-08-24 | 2018-08-28 | 500 | $4.85 | $2.4K | 1,400 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-08-24 | 2018-08-28 | 100 | $4.85 | $485 | 100 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-08-24 | 2018-08-28 | 400 | $4.99 | $2.0K | 500 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | A Award | 2018-03-15 | 2018-03-16 | 5,700 | $3.50 | $19.9K | 5,700 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | P Buy | 2018-03-15 | 2018-03-20 | 5,700 | $3.50 | $19.9K | 5,700 | SEC↗ |
| OHRP Ohr Pharmaceutical Inc | A Award deriv | 2017-10-16 | 2017-10-18 | 170,000 | — | $0 | 170,000 | SEC↗ |
| OHRP Ohr Pharmaceutical Inc | A Award deriv | 2016-01-07 | 2016-01-11 | 60,000 | — | $0 | 60,000 | SEC↗ |
| OHRP Ohr Pharmaceutical Inc | A Award deriv | 2015-03-10 | 2015-03-12 | 84,000 | — | $0 | 84,000 | SEC↗ |
| OHRP Ohr Pharmaceutical Inc | P Buy | 2015-02-06 | 2015-02-10 | 6,000 | $6.75 | $40.5K | 16,900 | SEC↗ |
| OHRP Ohr Pharmaceutical Inc | P Buy | 2014-09-03 | 2014-09-04 | 1,200 | $8.05 | $9.7K | 127,566 | SEC↗ |
| OHRP Ohr Pharmaceutical Inc | P Buy | 2014-09-02 | 2014-09-04 | 1,000 | $8.12 | $8.1K | 126,366 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer deriv | 2014-07-02 | 2014-07-07 | 21,970 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer deriv | 2014-07-02 | 2014-07-07 | 6,912 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer deriv | 2014-07-02 | 2014-07-07 | 83,000 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer deriv | 2014-07-02 | 2014-07-07 | 27,000 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer | 2014-07-02 | 2014-07-07 | 24,600 | — | $0 | 0 | SEC↗ |
| OHRP Ohr Pharmaceutical Inc | P Buy | 2014-06-26 | 2014-06-30 | 3,200 | $8.34 | $26.7K | 125,366 | SEC↗ |
| OHRP Ohr Pharmaceutical Inc | P Buy | 2014-04-08 | 2014-04-09 | 5,500 | $10.25 | $56.4K | 122,166 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2014-02-04 | 2014-02-06 | 27,000 | — | $0 | 104,718 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2014-02-04 | 2014-02-06 | 21,718 | — | $0 | 83,000 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2014-02-04 | 2014-02-06 | 43,939 | — | $0 | 21,970 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2014-02-04 | 2014-02-06 | 3,456 | — | $0 | 6,912 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2014-02-04 | 2014-02-06 | 19,000 | — | $0 | 27,000 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2014-02-04 | 2014-02-06 | 21,718 | $118.25 | $2.57M | 24,600 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2014-02-04 | 2014-02-06 | 3,456 | $17.80 | $61.5K | 139,713 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2014-02-04 | 2014-02-06 | 93,395 | $114.60 | $10.70M | 46,318 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2014-02-04 | 2014-02-06 | 19,000 | $15.00 | $285.0K | 92,318 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2014-02-04 | 2014-02-06 | 21,718 | $9.11 | $197.9K | 73,318 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2014-02-04 | 2014-02-06 | 27,000 | $9.11 | $246.0K | 51,600 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2014-02-04 | 2014-02-06 | 43,939 | $13.16 | $578.2K | 136,257 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | A Award | 2013-06-10 | 2013-06-12 | 17,600 | — | $0 | 24,600 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-08-15 | 2012-08-16 | 950 | $18.68 | $17.7K | 7,000 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-08-14 | 2012-08-16 | 50 | $18.55 | $928 | 6,050 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-05-17 | 2012-05-18 | 2,000 | $14.80 | $29.6K | 6,000 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | A Award deriv | 2012-02-24 | 2012-04-11 | 10,368 | — | $0 | 10,368 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | P Buy | 2012-02-24 | 2012-02-28 | 3,000 | $18.21 | $54.6K | 4,000 | SEC↗ |